Compile Data Set for Download or QSAR
Report error Found 67 with Last Name = 'kizhake' and Initial = 's'
TargetBreast cancer type 1 susceptibility protein(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50345640((S)-2-((2S,3R)-2-((S)-1-((S)-2-acetamido-3-(phosph...)
Affinity DataKd:  190nMAssay Description:Binding affinity to BRCA1 by isothermal titration calorimetric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed
TargetBreast cancer type 1 susceptibility protein(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50345642((2S,5S,8S,11S,14S)-2-((S)-2-((2S,3R)-1-((S)-1-((S)...)
Affinity DataKd:  440nMAssay Description:Binding affinity to BRCA1 by isothermal titration calorimetric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed
TargetBreast cancer type 1 susceptibility protein(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50345643(CHEMBL1784787)
Affinity DataKd:  410nMAssay Description:Binding affinity to BRCA1 by isothermal titration calorimetric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed
TargetCyclin-dependent kinase 9(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50570974(CHEMBL4846069)
Affinity DataKd:  1.07E+3nMAssay Description:Binding affinity to CDK9 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetCyclin-dependent kinase 9(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50570973(CHEMBL4864688)
Affinity DataKd:  1.06E+3nMAssay Description:Binding affinity to CDK9 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50570974(CHEMBL4846069)
Affinity DataKd:  230nMAssay Description:Binding affinity to CDK5 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50570973(CHEMBL4864688)
Affinity DataKd:  815nMAssay Description:Binding affinity to CDK5 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetCyclin-dependent kinase 2(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50570973(CHEMBL4864688)
Affinity DataKd:  385nMAssay Description:Binding affinity to CDK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetCyclin-dependent kinase 2(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50570974(CHEMBL4846069)
Affinity DataKd:  135nMAssay Description:Binding affinity to CDK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTyrosine-protein kinase BTK(Human)
Eppley Institute For Research In Cancer and Allied Diseases

Curated by ChEMBL
LigandPNGBDBM50357312(IBRUTINIB | US9181263, 1 | US9108973, Ref 1 | US92...)
Affinity DataIC50: 0.210nMAssay Description:Inhibition of BTK (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50570973(CHEMBL4864688)
Affinity DataIC50: 7nMAssay Description:Inhibition of CDK5 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5 activator 1(Human)
Eppley Institute For Research In Cancer and Allied Diseases

Curated by ChEMBL
LigandPNGBDBM50506700(CHEMBL4439395)
Affinity DataIC50: 23nMAssay Description:Inhibition of CDK5/p35 (unknown origin) in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Human)
Eppley Institute For Research In Cancer and Allied Diseases

Curated by ChEMBL
LigandPNGBDBM50506700(CHEMBL4439395)
Affinity DataIC50: 24nMAssay Description:Inhibition of CDK2/CyclinE (unknown origin) in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed
TargetCyclin-dependent kinase 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50570974(CHEMBL4846069)
Affinity DataIC50: 32nMAssay Description:Inhibition of CDK5 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetCyclin-dependent kinase 2(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50570974(CHEMBL4846069)
Affinity DataIC50: 44nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetCyclin-dependent kinase 2(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50570973(CHEMBL4864688)
Affinity DataIC50: 155nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetInhibitor of nuclear factor kappa-B kinase subunit beta(Human)
Eppley Institute For Research In Cancer and Allied Diseases

Curated by ChEMBL
LigandPNGBDBM50309910(N-(6-chloro-7-methoxy-9H-pyrido[3,4-b]indol-8-yl)-...)
Affinity DataIC50: 465nMAssay Description:Inhibition of IKKbeta (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed
TargetCyclin-dependent kinase 9(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50570973(CHEMBL4864688)
Affinity DataIC50: 530nMAssay Description:Inhibition of CDK9 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetCyclin-dependent kinase 9(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50506700(CHEMBL4439395)
Affinity DataIC50: 911nMAssay Description:Inhibition of CDK9 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed
TargetBreast cancer type 1 susceptibility protein(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50345640((S)-2-((2S,3R)-2-((S)-1-((S)-2-acetamido-3-(phosph...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed
TargetCyclin-dependent kinase 9(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50570974(CHEMBL4846069)
Affinity DataIC50: 1.08E+3nMAssay Description:Inhibition of CDK9 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetBreast cancer type 1 susceptibility protein(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50345641((S)-2-((S)-2-((S)-1-((S)-2-acetamido-3-(phosphonoo...)
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed
TargetBreast cancer type 1 susceptibility protein(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50345629((S)-2-acetamido-3-((S)-2-((S)-1-((S)-1-amino-1-oxo...)
Affinity DataIC50: 3.20E+3nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed
TargetInhibitor of nuclear factor kappa-B kinase subunit beta(Human)
Eppley Institute For Research In Cancer and Allied Diseases

Curated by ChEMBL
LigandPNGBDBM50572632(CHEMBL1760195)
Affinity DataIC50: 3.30E+3nMAssay Description:Inhibition of TNFalpha-induced IKKbeta mediated NF-kappaB activation in human Pancreatic cancer cells by luciferase reporter gene assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetBreast cancer type 1 susceptibility protein(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50345623((S)-2-acetamido-3-((S)-2-((2S,3R)-1-((S)-1-amino-1...)
Affinity DataIC50: 4.60E+3nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed
TargetBreast cancer type 1 susceptibility protein(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50345631((S)-2-acetamido-3-((S)-2-((2S,3S)-1-((S)-1-amino-1...)
Affinity DataIC50: 7.10E+3nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed
TargetInhibitor of nuclear factor kappa-B kinase subunit beta(Human)
Eppley Institute For Research In Cancer and Allied Diseases

Curated by ChEMBL
LigandPNGBDBM50572633(CHEMBL4865581)
Affinity DataIC50: 8.40E+3nMAssay Description:Inhibition of TNFalpha-induced IKKbeta mediated NF-kappaB activation in human Pancreatic cancer cells by luciferase reporter gene assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetHigh affinity nerve growth factor receptor(Human)
Eppley Institute For Research In Cancer and Allied Diseases

Curated by ChEMBL
LigandPNGBDBM50506700(CHEMBL4439395)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of TRKA (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed
TargetTyrosine-protein kinase ITK/TSK(Human)
Eppley Institute For Research In Cancer and Allied Diseases

Curated by ChEMBL
LigandPNGBDBM50506700(CHEMBL4439395)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of ITK (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed
TargetMitogen-activated protein kinase kinase kinase 12(Human)
Eppley Institute For Research In Cancer and Allied Diseases

Curated by ChEMBL
LigandPNGBDBM50506700(CHEMBL4439395)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of DLK (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed
TargetMitogen-activated protein kinase 10(Human)
Eppley Institute For Research In Cancer and Allied Diseases

Curated by ChEMBL
LigandPNGBDBM50506700(CHEMBL4439395)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of JNK3 (unknown origin) after 22 mins by homogeneous time-resolved fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed
TargetAurora kinase A(Human)
Eppley Institute For Research In Cancer and Allied Diseases

Curated by ChEMBL
LigandPNGBDBM50506700(CHEMBL4439395)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of Aurora A (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed
TargetMitogen-activated protein kinase 14(Human)
Eppley Institute For Research In Cancer and Allied Diseases

Curated by ChEMBL
LigandPNGBDBM50506700(CHEMBL4439395)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of MAPK14 (unknown origin) after 22 mins by homogeneous time-resolved fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 1(Human)
Eppley Institute For Research In Cancer and Allied Diseases

Curated by ChEMBL
LigandPNGBDBM50506700(CHEMBL4439395)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of PAK1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Eppley Institute For Research In Cancer and Allied Diseases

Curated by ChEMBL
LigandPNGBDBM50506700(CHEMBL4439395)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of LRRK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed
TargetTyrosine-protein kinase BTK(Human)
Eppley Institute For Research In Cancer and Allied Diseases

Curated by ChEMBL
LigandPNGBDBM50506700(CHEMBL4439395)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of BTK (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed
TargetInhibitor of nuclear factor kappa-B kinase subunit beta(Human)
Eppley Institute For Research In Cancer and Allied Diseases

Curated by ChEMBL
LigandPNGBDBM50506700(CHEMBL4439395)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of IKKbeta (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed
TargetAurora kinase B(Human)
Eppley Institute For Research In Cancer and Allied Diseases

Curated by ChEMBL
LigandPNGBDBM50506700(CHEMBL4439395)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of Aurora B (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed
TargetBreast cancer type 1 susceptibility protein(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50345639((S)-2-amino-3-((S)-2-((2S,3R)-1-((S)-1-amino-1-oxo...)
Affinity DataIC50: 1.08E+4nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed
TargetBreast cancer type 1 susceptibility protein(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50345635((S)-2-acetamido-3-((S)-2-((2S,3R)-1-((S)-1-amino-3...)
Affinity DataIC50: 1.49E+4nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed
TargetBreast cancer type 1 susceptibility protein(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50345627((S)-2-acetamido-3-((S)-1-((2S,3R)-1-((S)-1-amino-1...)
Affinity DataIC50: 1.50E+4nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed
TargetBreast cancer type 1 susceptibility protein(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50345633((2S)-2-acetamido-3-((2S)-2-((2S,3R)-1-(1-amino-3-(...)
Affinity DataIC50: 1.77E+4nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed
TargetBreast cancer type 1 susceptibility protein(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50345632((S)-2-acetamido-3-((S)-2-((S)-1-((S)-1-amino-1-oxo...)
Affinity DataIC50: 1.84E+4nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed
TargetBreast cancer type 1 susceptibility protein(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50345630((S)-2-acetamido-3-((S)-2-((S)-1-((S)-1-amino-1-oxo...)
Affinity DataIC50: 3.01E+4nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed
TargetBreast cancer type 1 susceptibility protein(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50345628((S)-2-acetamido-3-((S)-2-((S)-1-((S)-1-amino-1-oxo...)
Affinity DataIC50: 3.50E+4nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed
TargetBreast cancer type 1 susceptibility protein(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50345625(2-((S)-2-acetamido-3-((S)-2-((2S,3R)-1-((S)-1-amin...)
Affinity DataIC50: 5.28E+4nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed
TargetBreast cancer type 1 susceptibility protein(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50345636((S)-2-acetamido-3-((S)-1-((S)-1-((S)-1-amino-1-oxo...)
Affinity DataIC50: 9.84E+4nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed
TargetBreast cancer type 1 susceptibility protein(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50345634((2S)-2-acetamido-3-((2S)-2-((2S,3R)-1-(1-amino-3-(...)
Affinity DataIC50: 1.72E+5nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed
TargetBreast cancer type 1 susceptibility protein(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50345626((2R,3S)-3-acetamido-4-((S)-2-((2S,3R)-1-((S)-1-ami...)
Affinity DataIC50: 2.50E+5nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed
TargetBreast cancer type 1 susceptibility protein(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50345637((S)-2-acetamido-3-((S)-2-((S)-2-((S)-1-amino-1-oxo...)
Affinity DataIC50: 2.50E+5nMAssay Description:Inhibition of BRCA1 by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMed
Displayed 1 to 50 (of 67 total ) | Next | Last >>
Jump to: